DSM and BRAIN cooperate in the biotechnological production of water-soluble vitamins
DSM nutritional products GmbH, a subsidiary of the Dutch company Royal DSM N.V., and BRAIN AG announced a strategic cooperation in the biotechnological production of water-soluble vitamins.
An other collaboration between BRAIN AG and Royal DSM N.V. in the field of enzyme systems and strain development for fermentative production of special chemicals was already publicized at the beginning of 2009. The collaboration published today represents an important landmark in the corporate strategy of BRAIN, aimed at intensifying and boosting its cooperation business with globally successful partners within the chemical industry. For DSM Nutritional Products, this cooperation with BRAIN augments the network philosophy "Open Innovation“, where selected specialists deal with customized issues.
"By cooperating with BRAIN, DSM Nutritional Products will gain extensive access to the comprehensive technological platform of BRAIN for watersoluble vitamin production and extends DSM resources in this competitive sector. BRAIN possesses a unique portfolio of new enzymes and microbial synthetic pathways, which will allow us to develop new metabolic production pathways to further increase vitamin production efficiency," explains Dr. Hans-Peter Hohmann, Principal Scientist at DSM Nutritional Products. "We are also very pleased that this research venture will receive support from the funding initiative "BioIndustrie 2021" of the German Federal Ministry of Education and Research (BMBF). This emphasizes and validates the scientific quality and technological leadership of the undertaking."
"We are delighted that DSM Nutritional Products is already the second subsidiary of DSM N.V., which has decided to cooperate with us in a strategic partnership", says Dr. Jürgen Eck, Chief Scientific Officer of BRAIN AG. "Fermentative vitamin production has developed into a prime discipline of white biotechnology in the past decades. This is precisely why we need to delve deep into nature's toolbox in this intended project. We call this "Biologically inspired Engineering" and as cooperation partners this will also involve constructing completely new high-efficiency producers for fermentative vitamin production."
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
Marine compound discovery shows promise of improved drug treatment for COPD patients
Efficient Recycling Process for Rare Earths Through Bioleaching and Bioaccumulation - Great potential in the recovery of valuable materials from electronic waste: Up to 85% recovery of rare earths achieved in the laboratory
Evogene and Zeraim Gedera Salt Tolerant Tomato Collaboration Advances to Second Phase
Heptares granted patents covering stabilised receptor technology in Europe and Japan - Key patent grants protect Heptares’ leading position in GPCR-targeted drug design and discovery
Pevion’s therapeutic Candida vaccine shows robust systemic and mucosal immunogenicity
Covestro and Genomatica produce important chemical raw material using biotechnology - Breakthrough for HMDA, widely-used ingredient, paves the way for more sustainable coatings, apparel, adhesives and plastics
Amarin corporation Appoints Colin W. Stewart as President and Chief Executive Officer
Discovery of quantum vibrations in 'microtubules' corroborates theory of consciousness
Merck Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million - “Over the past decade, M Ventures has established itself globally as a leading partner to the biotech and tech venture ecosystems”
Genmab and Seattle Genetics Enter Into Antibody-Drug Conjugate Research Collaboration
